AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, AbCheck leverages both cutting-edge (e.g., microfluidics, rabbit mass humanization) and state-of-the-art (e.g., phage/yeast display libraries) technologies to provide high quality leads. The company has proven its capabilities in multiple partnerships throughout the U.S. and Europe. AbCheck is a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company.
Looking for a particular AbCheck s.r.o. employee's phone or email?
The AbCheck s.r.o. annual revenue was $2 million in 2026.
Volker Lang is the Managing Director of AbCheck s.r.o..
20 people are employed at AbCheck s.r.o..
AbCheck s.r.o. is based in Pilsen, Plzensky.
The NAICS codes for AbCheck s.r.o. are [54171, 5417, 54, 541, 541714].
The SIC codes for AbCheck s.r.o. are [87, 873].